In conclusion, Schizandrin C can attenuate liver fibrosis induced by CCl4, which is possibly via the regulation of lipid metabolism and inflammation mediated by NF-κB and p38/ERK MAPK signaling pathways. The gene discussed is NFKB1; the disease is Hepatic fibrosis.